Comparison of influential factors affecting survival of patients with colon and rectum cancer using competing risks model

Koomesh

Volumn 12, Issue 2, 2011, Pages 119-128

  Akhoond, Mohammad Reza ^a   Kazemnejad, Anooshiravan ^a   Hajizadeh, Ebrahim ^a   Motlagh, Ali Ganbary ^b   Zali, Mohammad Reza ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colon cancer; Competing risks; Rectum cancer; Survival

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; DATA ANALYSIS SOFTWARE; ENTERITIS; HUMAN; IRAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; SURVIVAL RATE;

EID: 78650506171     PISSN: 16087046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. GLOBOCAN. 2008; Available from: http://globocan. iarc.fr/factsheets/ cancers/colorectal.asp.
2. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F. and et al. Incidence and age distribution of colorectal cancer in Iran:Results of a populationbased cancer registry. Cancer Lett 2006;240:143-147.
3. Stewart, B. W. and P. Kleihues, World Cancer Report. International Agency for Research on Cancer, 2003.
4. Bulow S. Colorectal cancer in patients less than 40 years of age in Denmark. 1943-1967. Dis Colon Rectum 1980;23:327-336.
5. Cancer office. Office of Deputy Minister for Health Center for disease control, Ministry of Health and Medical Education, Islamic Republic of Iran. Iranian Annual National Cancer Registration Report. 2005: March 2007.
6. Roncucci L, Fante R, Losi L, Di Gregorio C, Micheli A, Benatti P. and et al. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 1996;32:295-302.
7. Hannisdal E. and Thorsen G. Regression analyses of prognostic factors in colorectal cancer. J Surg Oncol 1988;37:109-112.
8. Wiggers T, Arends JW. and Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988;31:33-41.
9. Griffin MR., Bergstralh EJ, Coffey RJ, Beart RW Jr. and Melton LJ 3rd. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60:2318-2324.
10. Liang S, Carlin BP. and Gelfand AE. Analysis of MINNESOTA colon and rectum cancer point patterns with spatial and nonspatial covariate information. Ann App Stat 2009;3:943-962.
11. Halvorsen TB. and Seim E. Tumor site: a prognostic factor in colorectal cancer? A multivariate analysis. Scand J Gastroenterol 1978;22:124-128.
12. Wolmark N, Wieand HS, Rockette HE, Fisher B, Glass A, Lawrence W. and et al. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg 1983;198:743-752.
13. Li M, Li JY, Zhao AL. and Gu J. Colorectal Cancer or Colon and Rectal Cancer? Clinicopathological Comparison between Colonic and Rectal Carcinomas. Oncology 2007;73:52-57.
14. Li FY. and Lai MD. Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009;10:219-229.
15. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-408.
16. Putter H, Fiocco M. and Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;26:2389-2430.
17. Gichangi, A. and W. Vach, The analysis of competing risks data: A guided tour. 2005: Department of Statistics, University of Southern Denmark.
18. Pintilie, M., Competing Risks: A Practical Perspective. 2006, Chichester, UK: Wiley.
19. Cleves MA, Gould WW, Gutierrez RG, Marchenko Y, et al. An Introduction to Survival Analysis Using STATA. 2008;2nd ed.
20. Klein JP. and ML. Moeschberger Survival Analysis: Statistical Methods for Censored and Truncated Data. 1997, NewYork: Springer-Verlag.
21. Kleinbaum and, D. G. and M. Klein, Survival Analysis-A Self-Learning Text. 2005, New York: Springer-Verlag.
22. Huang X. and Zhang N. Regression Survival Analysis with an Assumed Copula for Dependent Censoring: A Sensitivity Analysis Approach. Biometrics 2008;64:1090-1099.
23. Chen YH. Semiparametric marginal regression analysis for dependent competing risks under an assumed copula. Journal of the Royal Statistical Society Series B, 2010. 72: p. 235-251.
24. Hosseini SV, Izadpanah A. and Yarmohammadi H. Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg 2004;74:547-549.
25. Labianca R, Beretta G, Gatta G, de Braud F. and Wils J. Colon cancer. Crit Rev Oncol Hematol 2004;51:145-170.
26. Zampino MG, Labianca R, Beretta G, Gatta G, Lorrizo K, Braud Fd F. and Wils J. Rectal cancer. Crit Rev Oncol Hematol 2004;51: p. 121-143.
27. Xu FY, Zhai MJ, Dong JK, Wang FJ, Jin YS, Zhu YM, Lai MD. Clinical pathological factors function differently in colonic and rectal cancer prognosis. J Zhejiang Uni Med Sci, 2006;3:303-310.
28. Wilkes G. and Hartshorn K. Colon, Rectal, and Anal Cancers. Semin Oncol Nurs 2009;25:32-47.
29. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW. and et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-783.
30. Murphy TK, Calle EE, Rodriguez C, Kahn HS. and Thun MJ. Body Mass Index and Colon Cancer Mortality in a Large Prospective Study. Am J Epidemiol 2000;152:847-854.
31. Shibakita M, Yoshimura H, Tachibana M, Ueda S. and Nagasue N. Body mass index influences long-term outcome in patients with colorectal cancer. Hepatogastroenterology 2010;57:62-69.
32. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ. and Rankin C. Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors. Clin Cancer Res 2010;16:1884-1893.
33. Hines RB, Shanmugam C, Waterbor JW, McGwin G Jr, Funkhouser E, Coffey CS. and et al. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer 2009;115:5798-5806.
34. Yi SW, Sull JW, Linton JA, Nam CM. and Ohrr H. Alcohol Consumption and Digestive Cancer Mortality in Koreans: The Kangwha Cohort Study. J Epidemiol 2010;20:204-211.
35. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Nørgård B. and Sørensen HT. Survival After Colorectal Cancer in Patients with Crohn's Disease: A Nationwide Population-Based Danish Follow-Up Study. Am J Gastroenterol 2007;102:163-167.
36. Stucchi AF, Aarons CB. and Becker JM. Surgical Approaches to Cancer in Patients Who Have Inflammatory Bowel Disease. Gastroenterol Clin North Am 2006;35:641-673.
37. Park YJ, Park KJ, Park JG, Lee KU, Choe KJ. and Kim JP. Prognostic Factors in 2230 Korean Colorectal Cancer Patients: Analysis of Consecutively Operated Cases. World J Surg 1999;23:721-726.
38. Liang H, Wang XN, Wang BG, Pan Y, Liu N. and Wang DC. Prognostic factors of young patients with colon cancer after surgery. World J Gastroenterol 2006;12:1458-1462.
39. Ogata Y, Torigoe S, Matono K, Sasatomi T, Ishibashi N, Shida S. and et al. Prognostic Factors after Potentially Curative Resection in Stage II or III Colon Cancer. Kurume Med J 2005;52:67-71.
40. Liang JL, Wan DS, Pan ZZ, Zhou ZW, Chen G, Li LR. and et al. Multivariate regression analysis of recurrence following curative surgery for colorectal cancer. Ai Zheng 2004;23:564-567.
41. Aslam MI, Kelkar A, Sharpe D. and Jameson JS. Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers. Int J Surg 2010;8:305-313.
42. Enderlin F. and Gloor F. Colorectal cancer: The relationship of staging to survival A cancer registry study of 800 cases in St. Gallen-Appenzell. Soz Präventivmed 1986;31:85-88.
43. Xu FY, Di MJ, Dong JK, Wang FJ, Jin YS, Zhu YM. and Lai MD. Influence of clinical and pathomorphological parameters on prognosis in colon carcinoma and rectal carcinoma. Zhejiang Da Xue Xue Bao Yi Xue Ban 2006;35:303-310.
44. Casillas S, Pelley RJ. and Milsom JW. Adjuvant therapy for colorectal cancer: Present and future perspectives. Dis Colon Rectum 1997;40:977-992.
45. Taal BG, Van Tinteren H. and Zoetmulder FA; NACCP group. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 2001;85:1437-1443.
46. Xu JM, Qin XY, Zhong YS, Wei Y, Fan J, Zhou J. and et al. Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases. Zhonghua Zhong Liu Za Zhi 2007;29:54-57.